Notice Regarding Agilon Health Securities Class Action
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Globenewswire
- Class Action Notice: Rosen Law Firm reminds investors who purchased Agilon Health securities between February 26, 2025, and August 4, 2025, that they must apply to be lead plaintiff by March 2, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors participating in the class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which reduces financial barriers and encourages broader participation.
- Lawsuit Background: The lawsuit alleges that Agilon Health made false or misleading statements during the class period, resulting in investor losses when the true information was revealed, indicating significant missteps in the company's financial guidance and strategic actions.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource advantages in handling such cases.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like AGL with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on AGL
Wall Street analysts forecast AGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGL is 0.98 USD with a low forecast of 0.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
1 Buy
7 Hold
2 Sell
Hold
Current: 0.862
Low
0.50
Averages
0.98
High
1.50
Current: 0.862
Low
0.50
Averages
0.98
High
1.50
About AGL
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Notice Regarding Agilon Health Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Agilon Health securities between February 26, 2025, and August 4, 2025, that they must apply to be lead plaintiff by March 2, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors participating in the class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which reduces financial barriers and encourages broader participation.
- Lawsuit Background: The lawsuit alleges that Agilon Health made false or misleading statements during the class period, resulting in investor losses when the true information was revealed, indicating significant missteps in the company's financial guidance and strategic actions.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource advantages in handling such cases.
Continue Reading
Multiple Companies Face Class Action Lawsuits
- SLM Corporation Lawsuit: SLM Corporation is facing allegations for failing to disclose a significant rise in early-stage delinquencies during the class period from July 25 to August 14, 2025, misleading investors about the company's business prospects, with a lead plaintiff deadline of February 17, 2026.
- Klarna Group IPO Issues: Klarna Group is accused of materially understating the risk of increased loss reserves during its September 2025 IPO, which could undermine investor confidence in its business outlook, with a lead plaintiff deadline of February 20, 2026.
- agilon Health Misleading Guidance: agilon Health is facing claims for issuing unrealistic financial guidance during the period from February 26 to August 4, 2025, potentially misleading investors about the positive impact of its strategic actions, with a lead plaintiff deadline of March 2, 2026.
- Fermi Inc. Risk Concealment: Fermi Inc. is accused of overstating tenant demand for its Project Matador campus from October 1 to December 11, 2025, which could negatively affect investor confidence, with a lead plaintiff deadline of March 6, 2026.
Continue Reading